Top Biotechnology companies in United Kingdom by Capital Expenditure To Sales for September 19, 2024

This ranking features the top 5 Biotechnology companies in United Kingdom, based on their Capital Expenditure To Sales for September 19, 2024.

United Kingdom
Biotechnology
5 companies - Average Capital Expenditure To Sales: 37.64% 
Data sourced from iex and EODHD
Rank by
Download Data
#
Name
Capital Expenditure To Sales
Reported Date
Stock Price
Price (30 days)
Change
 Country
10 25 50
Frequently Asked Questions
  • Which Biotechnology company in United Kingdom has the highest Capital Expenditure To Sales ?

    The Biotechnology company in United Kingdom with the highest Capital Expenditure To Sales is Freeline Therapeutics Holdings Plc (NASDAQ: FRLN) at 120.00%.

  • Which Biotechnology company in United Kingdom has the lowest Capital Expenditure To Sales ?

    The Biotechnology company in United Kingdom with the lowest Capital Expenditure To Sales is Bicycle Therapeutics Ltd (NASDAQ: BCYC) at 0.06%.